Skip to main content
. Author manuscript; available in PMC: 2017 Apr 18.
Published in final edited form as: Cancer Res. 2000 Aug 15;60(16):4320–4323.

Fig. 3.

Fig. 3

Overexpression of cyclin D may disrupt the Rb pathway at several points: (a) it competes with p16 for interaction with cdk4/6, which then becomes activated to phosphorylate Rb (top); (b) cyclin D-cdk4/6 complexes sequester the cdk inhibitors p21 and p27 so that they are unavailable to block cdk2 (bottom). Cyclin E-cdk2 can then act downstream of Rb to initiate cell cycle progression into S phase. See text for details.